Evaluating remyelination compounds for new applications in opioid use disorder management
{{output}}
Opioid use disorder (OUD) is associated with a reduction in brain white matter, affecting critical areas involved in decision-making, impulse control, and reward processing. The FDA has approved several drugs and natural compounds that enhance myelination, tar... ...
